neoadjuv chemotherapi radic surgeri advanc cervic cancer prognost factor respons surviv between januari septemb patient advanc cervic carcinoma intern feder gynecolog obstetr figo stage ib-iii cours neoadjuv chemotherapi nac cisplatin bleomycin methotrex pbm fifteen percent patient complet respons CR partial respons PR pretreat characterist respons nac significantli respons rate patient tumor size cm diamet bilater parametri involv pelvic side wall none biolog paramet patient CR PR surviv rate nac radic surgeri possibl patient median number lymph node incid lymph node metastas none clinic patholog featur lymph node statu patient recurr patholog parametri involv cervic infiltr equal mm signific prognost factor recurr disease-fre surviv stage ib-iia iib iii oper patient rate stage ib-iia iib iii prospect trial nac surgeri radiotherapi progress 